Beactica Therapeutics
PrivateLast Round
Grant
Feb 17, 2026
Total Funding Raised
$762,000
Company Overview
Beactica Therapeutics is a drug discovery company developing a medicine discovery platform designed to facilitate the treatment of glioblastoma and other cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beactica Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Beactica Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2026 | ||||
| VC Round | Mar 23, 2021 | ||||
| Grant | Jun 18, 2019 | ||||
| VC Round | Jun 4, 2019 | ||||
| VC Round | Aug 28, 2018 | ||||
Grant | Apr 18, 2018 |
Beactica Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| European Commission (Horizon Europe) | Grant |
| Almi Invest AB | VC Round |
| Vinnova | Grant |
| Swelife | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Secured $3M in grant funding.
Beactica Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beactica Therapeutics's valuation, stock price, and market status.
